Search research articles
Contact Us
Filters
Showing results (31-40 of 122) with videos related to
Page
of 13
Sort By:
Plos One
|
June 6, 2012
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma
Olivier Mir, Romain Coriat, Benoit Blanchet, et al.
Cancer Chemotherapy and Pharmacology
|
August 24, 2023
Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection
Cléa Tardy, Alicja Puszkiel, Pascaline Boudou-Rouquette, et al.
Clinical Medicine (London, England)
|
August 3, 2021
Impact of the COVID-19 pandemic on the management of cancer patients: the experience of the cancer outpatients department of a university hospital in Paris
Camille Tlemsani, Jennifer Arrondeau, Sixtine De Percin, et al.
Investigational New Drugs
|
November 1, 2016
Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-old
Frederic Bigot, Pascaline Boudou-Rouquette, Jennifer Arrondeau, et al.
The Journal of Nutrition, Health & Aging
|
March 22, 2024
Prognostic impact of neurocognitive disorders in older patients with cancer: the ELCAPA prospective cohort study
Catherine Conti, Elena Paillaud, Marie Laurent, et al.
Bulletin Du Cancer
|
April 23, 2025
[Update of the recommendations for the management and treatment of giant cell bone tumors, on behalf of GroupOS]
Pascaline Boudou-Rouquette, Frédérique Larousserie, Valérie Dumaine, et al.
International Journal of Molecular Sciences
|
January 21, 2023
Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options
Camille Tlemsani, Frédérique Larousserie, Sixtine De Percin, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
March 7, 2017
Development and validation of an ELISA method for the quantification of nivolumab in plasma from non-small-cell lung cancer patients
Alicja Puszkiel, Gaëlle Noé, Pascaline Boudou-Rouquette, et al.
European Journal of Clinical Pharmacology
|
March 23, 2023
Predictive factors associated with pemetrexed acute toxicity
Mathilde Bonnet, Anne Jouinot, Pascaline Boudou-Rouquette, et al.
Cancers
|
June 5, 2019
Differential Kinase Activation in Peripheral Blood Mononuclear Cells from Non-Small-Cell Lung Cancer Patients Treated with Nivolumab
Gaëlle Noé, Audrey Bellesoeur, Lisa Golmard, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 122) with videos related to
Sort By:
Page
of 13
Plos One
|
June 6, 2012
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma
Olivier Mir, Romain Coriat, Benoit Blanchet, et al.
Cancer Chemotherapy and Pharmacology
|
August 24, 2023
Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection
Cléa Tardy, Alicja Puszkiel, Pascaline Boudou-Rouquette, et al.
Clinical Medicine (London, England)
|
August 3, 2021
Impact of the COVID-19 pandemic on the management of cancer patients: the experience of the cancer outpatients department of a university hospital in Paris
Camille Tlemsani, Jennifer Arrondeau, Sixtine De Percin, et al.
Investigational New Drugs
|
November 1, 2016
Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-old
Frederic Bigot, Pascaline Boudou-Rouquette, Jennifer Arrondeau, et al.
The Journal of Nutrition, Health & Aging
|
March 22, 2024
Prognostic impact of neurocognitive disorders in older patients with cancer: the ELCAPA prospective cohort study
Catherine Conti, Elena Paillaud, Marie Laurent, et al.
Bulletin Du Cancer
|
April 23, 2025
[Update of the recommendations for the management and treatment of giant cell bone tumors, on behalf of GroupOS]
Pascaline Boudou-Rouquette, Frédérique Larousserie, Valérie Dumaine, et al.
International Journal of Molecular Sciences
|
January 21, 2023
Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options
Camille Tlemsani, Frédérique Larousserie, Sixtine De Percin, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
March 7, 2017
Development and validation of an ELISA method for the quantification of nivolumab in plasma from non-small-cell lung cancer patients
Alicja Puszkiel, Gaëlle Noé, Pascaline Boudou-Rouquette, et al.
European Journal of Clinical Pharmacology
|
March 23, 2023
Predictive factors associated with pemetrexed acute toxicity
Mathilde Bonnet, Anne Jouinot, Pascaline Boudou-Rouquette, et al.
Cancers
|
June 5, 2019
Differential Kinase Activation in Peripheral Blood Mononuclear Cells from Non-Small-Cell Lung Cancer Patients Treated with Nivolumab
Gaëlle Noé, Audrey Bellesoeur, Lisa Golmard, et al.
Page
of 13